¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) 2021 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ(ICKSH 2021)-4¿ù 2ÀÏ : 2021-04-02

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) 2021 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ(ICKSH 2021)-4¿ù 2ÀÏ : 2021-04-02
±³À°ÀÏÀÚ : 2021-04-02
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2021 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ(ICKSH 2021)-4¿ù 2ÀÏ      
ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
´ã´çÀÚ : À±ÁöÇý
¿¬¶ôó : 02-566-6031  
À̸ÞÀÏ : hematology@kams.or.kr      
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú      
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 150,000¿ø      
ºñ°í ´ëÇÑÇ÷¾×ÇÐȸ ȸ¿ø £Ü50,000, Æç·Î¿ì/°£È£»ç/¿¬±¸¿ø £Ü30,000 Çлý/Àü°øÀÇ £Ü20,000, ºñȸ¿ø £Ü150,000      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 02ÀÏ Room 3 09:00~09:30 B-Cell Lymphoma''s New Genomics  °í¿µÀÏ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04¿ù 02ÀÏ Room 3 09:30~10:00 Immuno-Oncology for B-Cell Lymphomas  ÃÖÀ±¼®(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 04¿ù 02ÀÏ Room 3 10:00~10:30 Novel Combination Immunochemotherapy beyond CD20  ÀÌÁØÈ£(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 04¿ù 02ÀÏ Room 3 10:30~11:15 Genetic Landscape of Lymphoma and Novel Treatment Approaches  Wyndham Hopkins Wilson(National Cancer Institute USA) 
±³À°½Ã°£ 04¿ù 02ÀÏ Room 3 11:30~12:10 When and How to Treat Front-Line Chronic Lymphocytic Leukemia?  Susan O¡¯Brien(University of Cambridge USA) 
±³À°½Ã°£ 04¿ù 02ÀÏ Room 3 12:40~13:40 Adaptive natural killer cells facilitate effector functions of daratumumab in multiple myeloma  Á¶Çö¼ö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 02ÀÏ Room 1 13:55~14:40 The Evolution of Acute Leukemia Diagnostics and Its Place in Treatment  Elizabeth Macintyre(The Hôpital Necker-Enfants Malades France) 
±³À°½Ã°£ 04¿ù 02ÀÏ Room 1 14:40~15:10 Outcome of Autologous Transplant in T-Cell Lymphoma: Experience of NIHBT in Vietnam  Nguyen Vu Bao Anh(Hanoi Medical University Vietnam) 
±³À°½Ã°£ 04¿ù 02ÀÏ Room 1 15:10~15:40 Subcutaneous Panniculitis-like T-Cell Lymphoma  Udomsak Bunworasate(King Chulalongkorn Memorial Hospital Thailand) 
±³À°½Ã°£ 04¿ù 02ÀÏ Room 1 15:40~16:10 Update of Extranodal NK/T-cell Lymphoma: Treatment and Biology  ±è¼®Áø(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 04¿ù 02ÀÏ Room 1 16:25~16:45 Immunotherapy in AML: From alloSCT towards CAR-T Cell Therapy  Charles Craddock(Queen Elizabeth Hospital UK) 
±³À°½Ã°£ 04¿ù 02ÀÏ Room 1 16:45~17:05 The Emerging Role of MRD in AML  Gert Ossenkoppele(Amsterdam University The Netherlands) 
±³À°½Ã°£ 04¿ù 02ÀÏ Room 1 17:05~17:30 Therapeutic Potential of ATO to Overcome Resistance of Bcl-2 Inhibitor in AML  ÀåÁöÀº(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 02ÀÏ Room 1 17:30~17:55 MRD in AML  Á¶º´½Ä(°¡Å縯ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) 2021 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ(ICKSH 2021)-4¿ù 2ÀÏ : 2021-04-02""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) 2021 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ(ICKSH 2021)-4¿ù 3ÀÏ : 2021-04-03
´ÙÀ½±Û (¿Â¶óÀÎ) 1Çбâ À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ - ±¸°­ÀÛ¿­ÁõÈıº(Burning mouth syndrome) : 2021-04-01
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
570 °­¿ø °­¸ª¾Æ»êº´¿ø 2018³â ´ëÇÑÀӻ󵶼ºÇÐȸ Çмú´ëȸ : 2018-09-07 0 846 2018-08-29
569 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ Pediatric CRRT 2018 : 2018-09-07 0 984 2018-08-29
568 ´ëÀü °Ç¾ç´ëÇб³ Á¦92Â÷ ´ëÇѽŰæ¿Ü°úÇÐȸ ´ëÀüÃæûÁöȸ Çмú Áý´ãȸ : 2018-09-07 0 1,190 2018-08-29
567 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ : 2018-09-06 0 698 2018-08-29
566 ´ë±¸ µ¿»êº´¿ø ´ëÇÑ¿µ»óÀÇÇÐȸ ´ë±¸°æºÏÁöȸ 9¿ù Áý´ãȸ : 2018-09-06 0 1,001 2018-08-29
565 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø ôÃߺ´¿ø 9¿ù ¿ù·ÊÁý´ãȸ : 2018-09-06 0 2,668 2018-08-29
564 ¼­¿ï °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¾È°úÇб³½Ç Áý´ãȸ : 2018-09-06 0 834 2018-08-29
563 °æ±â ¾ÆÁÖ´ëÇк´¿ø ºñ´¢ÀÇÇаú Áö¿ªÀÇ»çÁý´ãȸ : 2018-09-06 1 757 2018-08-29
562 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø 2018³â ´ëÇѼöÇ÷ÇÐȸ ÇмúÁý´ãȸ : 2018-09-06 0 685 2018-08-29
561 ÀÎõ °¡ÃµÀÇ´ë±æº´¿ø °íÀ§Çè »ê¸ð½Å»ý¾Æ ÅëÇÕÄ¡·á¼¾ÅÍ ¿ªÇÒ ¹× ¿î¿µ¹æÇâ : 2018-09-06 [2] 0 1,307 2018-08-29
560 ¼­¿ï °í´ë¾È¾Ïº´¿ø ¼Ò¾Æû¼Ò³â°ú ¿ù·Ê Áý´ãȸ : 2018-09-05 0 804 2018-08-29
559 °æ±â ´ëÇÑÀÓ»ó°Ë»çÁ¤µµ°ü¸®ÇÐȸ 2018³âµµ Ãß°èÇмú´ëȸ : 2018-09-05 0 1,301 2018-08-29
558 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦ 3Â÷ °³¿øÀǸ¦ À§ÇÑ ´ëÇѺÎÁ¤¸ÆÇÐȸ ¿¬¼ö±³À° : 2018-09-04 0 1,146 2018-08-29
557 ºÎ»ê ´ëÇѺ´¸®ÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ À¯¹æ ¹× ºñ´¢»ý½Ä±â°è º´¸®ÀÇ ÃÖ½ÅÁö°ß : 2018-09-04 0 902 2018-08-29
556 ¼­¿ï ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ ¿ù·ÊÁý´ãȸ : 2018-09-04 0 947 2018-08-29
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷